These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23882034)

  • 1. Introduction to the 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy).
    Del Prato S; Raz I
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S111-2. PubMed ID: 23882034
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction to the 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy).
    Raz I; Cefalu WT; Ilkova H; Del Prato S
    Diabetes Care; 2016 Aug; 39 Suppl 2(Suppl 2):S113-4. PubMed ID: 27440822
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction to the Second World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): dilemmas in clinical practice.
    Raz I
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S149-50. PubMed ID: 19875542
    [No Abstract]   [Full Text] [Related]  

  • 4. The 2nd China Congress on Controversies to Consensus in Diabetes, Obesity, and Hypertension (CODHy).
    J Diabetes; 2013 Sep; 5(3):228-32. PubMed ID: 24069611
    [No Abstract]   [Full Text] [Related]  

  • 5. The Controversies in Obesity, Diabetes and Hypertension (CODHy) meeting: what is it all about?
    Raz I; Weiss R
    Diabetes Care; 2008 Feb; 31 Suppl 2():S111-2. PubMed ID: 18227469
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction to the Third World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): outcome studies versus clinical experience in the treatment of diabetes.
    Raz I; Del Prato S
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S99-100. PubMed ID: 21525487
    [No Abstract]   [Full Text] [Related]  

  • 7. Seventh World congress on controversies to consensus in diabetes, obesity, and hypertension.
    Kurian MJ; Rentzepis PJ; Carracher AM; Close KL
    J Diabetes; 2019 Aug; 11(8):628-631. PubMed ID: 31012279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Break the "HOLD": The Need to Strengthen the Management of Hypertension, Obesity, Lipids, and Diabetes (HOLD) and Improve Cardiovascular Health in People With Diabetes.
    Abushamat LA; Nambi V
    J Am Heart Assoc; 2023 May; 12(10):e029944. PubMed ID: 37183835
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes, obesity, and the metabolic syndrome: a call for papers for EASD and the World Diabetes Congress.
    Berman P; Davies J; Horton R
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):591. PubMed ID: 26144066
    [No Abstract]   [Full Text] [Related]  

  • 10. Preface: Chronic diseases in childhood obesity: risks and benefits of early intervention. Ohio, April 2-3, 2009.
    Teich S; Michalsky MP
    Semin Pediatr Surg; 2009 Aug; 18(3):125. PubMed ID: 19573753
    [No Abstract]   [Full Text] [Related]  

  • 11. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem.
    Wyatt SB; Winters KP; Dubbert PM
    Am J Med Sci; 2006 Apr; 331(4):166-74. PubMed ID: 16617231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths.
    Mazloumi E; Poorolajal J; Sarrafzadegan N; Roohafza HR; Faradmal J; Karami M
    High Blood Press Cardiovasc Prev; 2019 Jun; 26(3):227-237. PubMed ID: 31228169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Bozkurt B; Aguilar D; Deswal A; Dunbar SB; Francis GS; Horwich T; Jessup M; Kosiborod M; Pritchett AM; Ramasubbu K; Rosendorff C; Yancy C;
    Circulation; 2016 Dec; 134(23):e535-e578. PubMed ID: 27799274
    [No Abstract]   [Full Text] [Related]  

  • 14. Current limitations in the management of cardiovascular risk in rheumatoid arthritis.
    Scott IC; Ibrahim F; Johnson D; Scott DL; Kingsley GH
    Clin Exp Rheumatol; 2012; 30(2):228-32. PubMed ID: 22325679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 63-year-old man with multiple cardiovascular risk factors and poor adherence to treatment plans.
    Bodenheimer T
    JAMA; 2007 Nov; 298(17):2048-55. PubMed ID: 17986698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemic of obesity and diabetes: trends and treatments.
    Barnes AS
    Tex Heart Inst J; 2011; 38(2):142-4. PubMed ID: 21494521
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood pressure and diabetes: vicious twins.
    Chokshi NP; Grossman E; Messerli FH
    Heart; 2013 Apr; 99(8):577-85. PubMed ID: 23434624
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in Cardiovascular Health of US Adults by Income, 2005-2014.
    Beckman AL; Herrin J; Nasir K; Desai NR; Spatz ES
    JAMA Cardiol; 2017 Jul; 2(7):814-816. PubMed ID: 28593300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa.
    Longo-Mbenza B; Ngoma DV; Nahimana D; Mayuku DM; Fuele SM; Ekwanzala F; Beya C
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):503-8. PubMed ID: 18830083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prioritisation of sugar to tackle obesity.
    Saksena R; Scherdel L
    Lancet Glob Health; 2015 Aug; 3(8):e447. PubMed ID: 26187489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.